Table 4.
DFS and OS rates stratified by tumour markers and univariate Cox analysis at stage II
| |
|
|
D.F.S. |
O.S |
Univariate Cox analysis |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Tumour marker | Levels | n | Mean (Months) | Recurrence% | Mean (Months) | Death% |
Recurrence RH 95% CI |
Death RH 95% CI |
||
| CA 72.4 |
≤ 7 |
33 |
59.89 |
9.09 |
61.40 |
6.06 |
1.00 |
(ref) |
1.00 |
(ref) |
| U/mL |
> 7 |
7 |
30.61a |
57.14 |
35.84b |
42.86 |
9.39 |
(2.05-43.05)c |
8.40 |
(1.40-50.43)d |
| CEA |
≤ 10 |
33 |
58.21 |
12.12 |
60.05 |
9.09 |
1.00 |
(ref) |
1.00 |
(ref) |
| ng/mL | > 10 | 7 | 36.87e | 42.86 | 39.89f | 28.57 | 4.05 | (0.90-18.23)g | 3.44 | (0.57-20.64)h |
Abbreviations: DFS, disease free survival; OS, overall survival; RH, relative hazard; 95% CI, 95% confidence interval; ref, reference.
aP <0.0001, bP = 0.005, cP = 0.004, dP = 0.02, eP = 0.05, fP = 0.15, gP = 0.07, hP = 0.17.